Literature DB >> 27005989

Brain-Derived Neurotrophic Factor Val66Met Polymorphism Affects the Relationship Between an Anxiety-Related Personality Trait and Resting Regional Cerebral Blood Flow.

Shau-Ming Wei1,2, Daniel P Eisenberg1,2, Katherine G Nabel1,2, Philip D Kohn1,2, J Shane Kippenhan1,2, Dwight Dickinson2, Bhaskar Kolachana2, Karen F Berman1,2.   

Abstract

Brain-derived neurotrophic factor (BDNF) is an important modulator of constitutive stress responses mediated by limbic frontotemporal circuits, and its gene contains a functional polymorphism (Val66Met) that may influence trait stress sensitivity. Reports of an association of this polymorphism with anxiety-related personality traits have been controversial and without clear neurophysiological support. We, therefore, determined the relationship between resting regional cerebral blood flow (rCBF) and a well-validated measure of anxiety-related personality, the TPQ Harm Avoidance (HA) scale, as a function of BDNF Val66Met genotype. Sixty-four healthy participants of European ancestry underwent resting H215O positron emission tomography scans. For each genotype group separately, we first determined the relationship between participants' HA scores and their resting rCBF values in each voxel across the entire brain, and then directly compared these HA-rCBF relationships between Val66Met genotype groups. HA-rCBF relationships differed between Val homozygotes and Met carriers in several regions relevant to stress regulation: subgenual cingulate, orbital frontal cortex, and the hippocampal/parahippocampal region. In each of these areas, the relationship was positive in Val homozygotes and negative in Met carriers. These data demonstrate a coupling between trait anxiety and basal resting blood flow in frontolimbic neurocircuitry that may be determined in part by genetically mediated BDNF signaling. Published by Oxford University Press 2016. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  BDNF genotype; PET; frontolimbic circuitry; harm avoidance; resting rCBF

Mesh:

Substances:

Year:  2017        PMID: 27005989      PMCID: PMC6059093          DOI: 10.1093/cercor/bhw072

Source DB:  PubMed          Journal:  Cereb Cortex        ISSN: 1047-3211            Impact factor:   5.357


  52 in total

1.  Temperament and character traits in patients with bipolar disorder and associations with comorbid alcoholism or anxiety disorders.

Authors:  Fabiano G Nery; John P Hatch; David C Glahn; Mark A Nicoletti; E Serap Monkul; Pablo Najt; Manoela Fonseca; Charles L Bowden; C Robert Cloninger; Jair C Soares
Journal:  J Psychiatr Res       Date:  2007-08-06       Impact factor: 4.791

2.  Deep brain stimulation for treatment-resistant depression.

Authors:  Helen S Mayberg; Andres M Lozano; Valerie Voon; Heather E McNeely; David Seminowicz; Clement Hamani; Jason M Schwalb; Sidney H Kennedy
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

3.  BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects.

Authors:  Xueying Jiang; Ke Xu; Joelle Hoberman; Feng Tian; Aimee J Marko; Juwaria F Waheed; Claudia R Harris; Ann M Marini; Mary-Anne Enoch; Robert H Lipsky
Journal:  Neuropsychopharmacology       Date:  2005-07       Impact factor: 7.853

Review 4.  The neurobiology of anxiety disorders: brain imaging, genetics, and psychoneuroendocrinology.

Authors:  Elizabeth I Martin; Kerry J Ressler; Elisabeth Binder; Charles B Nemeroff
Journal:  Clin Lab Med       Date:  2010-12       Impact factor: 1.935

Review 5.  A critical review of the first 10 years of candidate gene-by-environment interaction research in psychiatry.

Authors:  Laramie E Duncan; Matthew C Keller
Journal:  Am J Psychiatry       Date:  2011-09-02       Impact factor: 18.112

Review 6.  The neurocircuitry of fear, stress, and anxiety disorders.

Authors:  Lisa M Shin; Israel Liberzon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

7.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

Authors:  M A Smith; S Makino; R Kvetnansky; R M Post
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

8.  Meta-analysis of the brain-derived neurotrophic factor gene (BDNF) Val66Met polymorphism in anxiety disorders and anxiety-related personality traits.

Authors:  Alessandra Frustaci; Gino Pozzi; Francesco Gianfagna; Lamberto Manzoli; Stefania Boccia
Journal:  Neuropsychobiology       Date:  2008-12-17       Impact factor: 2.328

9.  Developmental expression of brain derived neurotrophic factor mRNA by neurons of fetal and adult monkey prefrontal cortex.

Authors:  G W Huntley; D L Benson; E G Jones; P J Isackson
Journal:  Brain Res Dev Brain Res       Date:  1992-11-20

10.  The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function.

Authors:  Michael F Egan; Masami Kojima; Joseph H Callicott; Terry E Goldberg; Bhaskar S Kolachana; Alessandro Bertolino; Eugene Zaitsev; Bert Gold; David Goldman; Michael Dean; Bai Lu; Daniel R Weinberger
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

View more
  11 in total

1.  Interactive effect of 5-HTTLPR and BDNF polymorphisms on amygdala intrinsic functional connectivity and anxiety.

Authors:  Joshua Loewenstern; Xiaozhen You; Junaid Merchant; Evan M Gordon; Melanie Stollstorff; Joseph Devaney; Chandan J Vaidya
Journal:  Psychiatry Res Neuroimaging       Date:  2019-01-29       Impact factor: 2.376

2.  Brain-derived neurotrophic factor signaling mitigates the impact of acute social stress.

Authors:  Anna M Rosenhauer; Linda Q Beach; Elizabeth C Jeffress; Brittany M Thompson; Katharine E McCann; Katherine A Partrick; Bryan Diaz; Alisa Norvelle; Dennis C Choi; Kim L Huhman
Journal:  Neuropharmacology       Date:  2018-12-14       Impact factor: 5.250

Review 3.  A review on shared clinical and molecular mechanisms between bipolar disorder and frontotemporal dementia.

Authors:  Camila Nascimento; Villela Paula Nunes; Roberta Diehl Rodriguez; Leonel Takada; Cláudia Kimie Suemoto; Lea Tenenholz Grinberg; Ricardo Nitrini; Beny Lafer
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2019-04-20       Impact factor: 5.067

4.  Brain-derived neurotrophic factor Val66Met genotype and ovarian steroids interactively modulate working memory-related hippocampal function in women: a multimodal neuroimaging study.

Authors:  S-M Wei; E B Baller; P D Kohn; J S Kippenhan; B Kolachana; S J Soldin; D R Rubinow; P J Schmidt; K F Berman
Journal:  Mol Psychiatry       Date:  2017-04-18       Impact factor: 15.992

5.  The Relationship Among BDNF Val66Met Polymorphism, Plasma BDNF Level, and Trait Anxiety in Chinese Patients With Panic Disorder.

Authors:  Lijun Chu; Xia Sun; Xiaoju Jia; Dazhi Li; Ping Gao; Yong Zhang; Jie Li
Journal:  Front Psychiatry       Date:  2022-06-23       Impact factor: 5.435

6.  BDNF, 5-HT, and Anxiety: Identification of a Critical Periadolescent Developmental Period.

Authors:  Ronald S Duman
Journal:  Am J Psychiatry       Date:  2017-12-01       Impact factor: 18.112

7.  Investigating the link between serum concentrations of brain-derived neurotrophic factor and behavioral measures in anxious alcohol-dependent individuals.

Authors:  Jeanelle Portelli; Mehdi Farokhnia; Sara L Deschaine; Jillian T Battista; Mary R Lee; Xiaobai Li; Dorit Ron; Lorenzo Leggio
Journal:  Alcohol       Date:  2020-08-13       Impact factor: 2.405

8.  The role of BDNF methylation and Val66 Met in amygdala reactivity during emotion processing.

Authors:  Ronny Redlich; Ilona Schneider; Nicole Kerkenberg; Nils Opel; Jonas Bauhaus; Verena Enneking; Jonathan Repple; Elisabeth J Leehr; Dominik Grotegerd; Claas Kähler; Katharina Förster; Katharina Dohm; Susanne Meinert; Tim Hahn; Harald Kugel; Kathrin Schwarte; Christiane Schettler; Katharina Domschke; Volker Arolt; Walter Heindel; Bernhard T Baune; Weiqi Zhang; Christa Hohoff; Udo Dannlowski
Journal:  Hum Brain Mapp       Date:  2019-10-15       Impact factor: 5.038

9.  Habenula Connectivity and Intravenous Ketamine in Treatment-Resistant Depression.

Authors:  Ana Maria Rivas-Grajales; Ramiro Salas; Meghan E Robinson; Karen Qi; James W Murrough; Sanjay J Mathew
Journal:  Int J Neuropsychopharmacol       Date:  2021-05-18       Impact factor: 5.176

10.  Cerebellar BDNF Promotes Exploration and Seeking for Novelty.

Authors:  Daniela Laricchiuta; Diego Andolina; Francesco Angelucci; Francesca Gelfo; Erica Berretta; Stefano Puglisi-Allegra; Laura Petrosini
Journal:  Int J Neuropsychopharmacol       Date:  2018-05-01       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.